| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2009 | US20090202510 Altered sumoylation of lamin a protein associated with dilated cardiomyopathy |
| 08/13/2009 | US20090202508 Negative regulation of hypoxia inducible factor 1 by os-9 |
| 08/13/2009 | US20090202507 Intelligent Nanomedicine Integrating Diagnosis And Therapy |
| 08/13/2009 | US20090202505 Rescue of Photoreceptors by Intravitreal Administration of an Expression Vector Encoding a Therapeutic Protein |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | US20090202502 Hepatic stellate cell specific promoter and uses thereof |
| 08/13/2009 | US20090202491 Method for modulating, regulating and/or stabilizing angiogenesis |
| 08/13/2009 | US20090202488 Use Of The Foamy Virus Bet Protein For Inactivating APOBEC |
| 08/13/2009 | US20090202484 Modulators of toll-like receptor 7 |
| 08/13/2009 | US20090202483 Hepatitis C Virus Inhibitors |
| 08/13/2009 | US20090202480 Macrocyclic serine protease inhibitors |
| 08/13/2009 | US20090202478 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials |
| 08/13/2009 | US20090202476 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide |
| 08/13/2009 | US20090202475 Compositions and methods for treatment of microbial disorders |
| 08/13/2009 | US20090202471 Molecules with effects on cellular development and function |
| 08/13/2009 | US20090202470 Phosphonate Analogs of Hiv Inhibitor Compounds |
| 08/13/2009 | US20090202467 Sclerotherapy for varicose veins |
| 08/13/2009 | US20090202463 Antimicrobial compositions, products and methods employing same |
| 08/13/2009 | US20090202457 Method for exfoliating skin |
| 08/13/2009 | US20090202456 Novel salts and their uses |
| 08/13/2009 | US20090202449 Use of osteopontin in dental formulations |
| 08/13/2009 | US20090202448 Metal lactate powder and method for preparation |
| 08/13/2009 | US20090202445 Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children. |
| 08/13/2009 | US20090202443 Methods of improving skin quality |
| 08/13/2009 | US20090202442 Enerceutical activation of the alternative cellular energy (ACE) pathway in therapy of diseases |
| 08/13/2009 | US20090202439 Methods for treatment of angiogenesis |
| 08/13/2009 | US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases |
| 08/13/2009 | US20090202436 Bupivacaine Formulation in a Polyorthoester Carrier |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | US20090200185 Systems and methods for administering a medical regimen |
| 08/13/2009 | DE69322992C5 Optisch reines Cis-oxalato(trans-l-1,2-Cyclohexandiamine)Pt(II) und Verfahren zur Auflösung von optischen Isomeren einer Platinkomplexverbindung Optically pure cis-oxalato (trans-l-1,2-Cyclohexandiamine) Pt (II) and methods for the resolution of optical isomers of a platinum complex compound |
| 08/13/2009 | DE202009006461U1 Kombination von Tocotrienolen mit ungesättigten Fettsäuren als Mittel zum Schutz des Herz/Kreislaufsystems, vor Krebserkrankungen, zur Entzündungshemmung, zur Steigerung der geistigen Leistungsfähigkeit und gegen Altersbeschwerden Combination of tocotrienols with unsaturated fatty acids as a means to protect the heart / circulatory system against cancer, reduces inflammation, increase mental performance and complaints against age |
| 08/13/2009 | DE102008008554A1 Kosmetische oder medizinische Zubereitung enthaltend Biotin Cosmetic or medicinal preparation containing biotin |
| 08/13/2009 | DE102008008497A1 Produkt aus O-acylierter Hydroxycarbonsäure und Aminosäure, ihre Herstellung, biologische Aktivitäten, kosmetisch oder pharmazeutisch wirksame Zusammensetzungen sowie Verwendung derselben insbesondere als Lebensmittelzusatzstoff und als Kosmetikzusatzstoff Product of O-acylated amino acid and hydroxycarboxylic acid, their preparation and biological activities, cosmetically or pharmaceutically effective compositions, and use thereof in particular, as a food additive and as a cosmetic additive |
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | DE102008007198A1 Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften Orally or nasally administered epinephrine-containing formulations with improved properties |
| 08/13/2009 | DE102004034747B4 Salbenzubereitung geeignet bei neurodermitischen Hauterkrankungen Ointment formulation suitable for neurodermatitis skin diseases |
| 08/13/2009 | CA2828861A1 Oral care product and methods of use and manufacture thereof |
| 08/13/2009 | CA2724230A1 Platinum aggregates and process for producing the same |
| 08/13/2009 | CA2722536A1 Prodrugs of cgrp receptor antagonist |
| 08/13/2009 | CA2715483A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 08/13/2009 | CA2715353A1 Use of picoplatin and cetuximab to treat colorectal cancer |
| 08/13/2009 | CA2715329A1 Picoplatin and amrubicin to treat lung cancer |
| 08/13/2009 | CA2715266A1 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | CA2715260A1 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure |
| 08/13/2009 | CA2714966A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | CA2714516A1 Abca-1 elevating compounds and the use thereof |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714426A1 Methods and compositions for treating respiratory disease |
| 08/13/2009 | CA2714420A1 Phosphate derivatives of substituted benzoxazoles |
| 08/13/2009 | CA2714419A1 Dual pharmacophores - pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714418A1 Dual pharmacophores - pde4 -muscarinic antagonistics |
| 08/13/2009 | CA2714410A1 Disease markers and uses thereof |
| 08/13/2009 | CA2714398A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 08/13/2009 | CA2714389A1 Macrolides and uses of macrolides |
| 08/13/2009 | CA2714370A1 Compounds that enhance atoh-1 expression |
| 08/13/2009 | CA2714352A1 Dual pharmacophores-pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714350A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | CA2714347A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | CA2714272A1 Therapeutic treatment for lung conditions |
| 08/13/2009 | CA2714237A1 Immunosuppressive macrolide powder for oral suspension |
| 08/13/2009 | CA2714232A1 Pyridinyl amides for the treatment of cns and metabolic disorders |
| 08/13/2009 | CA2714231A1 Topical antimicrobial compositions |
| 08/13/2009 | CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | CA2714200A1 Method for improving storage stability of glutathione |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/13/2009 | CA2714177A1 Pyrrolo [2,3-d] pyridines and use thereof as tyrosine kinase inhibitors |
| 08/13/2009 | CA2714113A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | CA2714112A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | CA2714043A1 Methods and compositions for treating inflammatory bowel disease |
| 08/13/2009 | CA2713958A1 Substituted cyclopentanes having prostaglandin activity |
| 08/13/2009 | CA2713943A1 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof |
| 08/13/2009 | CA2713899A1 Antimicrobial agents for the treatment of campylobacter species in the crop of a bird |
| 08/13/2009 | CA2713864A1 Certain chemical entities, compositions and methods |
| 08/13/2009 | CA2713855A1 Benzylpiperizine compound |
| 08/13/2009 | CA2713849A1 Crosslinked polysaccharides and methods of production thereof |
| 08/13/2009 | CA2713848A1 Anti-influenza compounds |
| 08/13/2009 | CA2713770A1 Methods of treating skin with aromatic skin-active ingredients |
| 08/13/2009 | CA2713768A1 Substituted furans and use thereof |
| 08/13/2009 | CA2713554A1 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713551A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713550A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713547A1 Biaryl amides |
| 08/13/2009 | CA2713521A1 Use of ranolazine for treating pain |
| 08/13/2009 | CA2713447A1 Extended release hydrocodone acetaminophen and related methods and uses thereof |
| 08/13/2009 | CA2713438A1 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | CA2713409A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| 08/13/2009 | CA2713380A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | CA2713377A1 Protective effect of high dose folate on mycardial ischemia |
| 08/13/2009 | CA2713361A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 08/13/2009 | CA2713322A1 Compounds |
| 08/13/2009 | CA2713173A1 (dihydro)pyrrolo[2,1-.alpha.]isoquinolines |
| 08/13/2009 | CA2712971A1 Macrocyclic serine protease inhibitors |
| 08/13/2009 | CA2712858A1 Novel process for the preparation of vorinostat |
| 08/13/2009 | CA2712800A1 Compositions and methods for alleviating depression or improving cognition |